Nephrocare India, a leading institution in advanced renal care, is charting ambitious expansion plans, aiming to establish 300 comprehensive renal care clinics across the country within the next decade or so. To fuel this growth, the institution is exploring various avenues for raising funds, including a potential initial public offering (IPO).

The institution recently concluded a successful pre-IPO round, securing investments from prominent figures such as veteran banker Deepak Parekh, Bharat Shah, Chairman of HDFC Securities, and Rajendra Agarwal, Founder and MD of Macleods Pharmaceuticals, among others.

Currently focusing on expanding its presence in eastern India, Nephrocare India is set to establish a comprehensive clinic in Balasore, Odisha, and has plans to venture into the western region with a clinic in Mumbai, Maharashtra during the fiscal year 2024-25.

Founded in 2014 by nephrologist Dr. Pratim Sengupta, Nephrocare India operates four comprehensive renal care units in West Bengal. The institution aims to add two more clinics in the state, with plans to expand further into other states including Chattisgarh and Assam in the near future. By March 2026, Nephrocare India aims to have close to 22 high-end kidney care facilities across eastern and western India.

Dr. Pratim Sengupta, Founder & MD of Nephrocare India, emphasized the institution's commitment to strengthening its presence in the eastern and northeastern regions through the hub and spoke model, while also expanding into new territories. He highlighted the imperative nature of the expansion, particularly in light of the rising prevalence of kidney diseases in India

With India facing a significant burden of kidney disease, marked by high rates of renal failure patients, Nephrocare India's expansion efforts underscore the pressing need for advanced renal care facilities across the country. As the institution marches forward with its expansion plans, attention turns to the potential avenues for funding its ambitious growth trajectory, including the possibility of tapping into the capital markets through an IPO.